Triangle’s G1 Therapeutics reaches key milestone in fight against cancer
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…
Life Sciences
Novavax, partnering with Morrisville firm, lands Covid-19 vaccine deal with U.K.
Date Published:
Novavax Inc. has locked in a deal to provide 60 million doses of its Covid-19 vaccine to the United Kingdom,…
Raleigh pharma gets FDA approval to explore Covid-19 treatment
Date Published:
Coming fresh off a $200 million raise, a drugmaker with a growing operation in the Triangle has received the go-ahead…
RedHill plans growth, more cash with Irish deal
Date Published:
A Raleigh drugmaker pushing ahead with development of its drug portfolio has signed a series of deals with an Irish…
Backstory: A look at RTP’s growing gene therapy hub as startup brings 200+ $102,000 jobs to Durham
Date Published:
RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…
Beam Therapeutics to build $83M manufacturing facility in RTP, create hundreds of jobs
Date Published:
RALEIGH — Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83…
Gene-editing company to add 200 jobs in Durham after getting North Carolina incentives
Date Published:
Durham has landed another gene-therapy jobs expansion after the state offered incentives to the biotechnology company Beam Therapeutics.
Beam, based…
TrialCard wins first federal contract – for fight against HIV
Date Published:
A Morrisville pharmaceutical solutions company has landed its first federal contract, a huge milestone as it will help lead the…
New RTP startup backed by Eshelman aims at cancer treatment
Date Published:
With financial backing from one of North Carolina’s most influential venture capitalists, a new company based in Research Triangle Park…